Andrew J S Knox - Search Results

Year	Number of Results
2005	1
2006	3
2007	5
2008	2
2009	2
2010	5
2011	4
2012	1
2013	1
2014	1
2016	1
2017	1
2018	1
2019	1
2020	3
2021	1
2024	0

1

Jigar Panchal H, Kent NJ, Knox AJS, Harris LF. Jigar Panchal H, et al. Among authors: knox ajs. Molecules. 2020 Feb 14;25(4):833. doi: 10.3390/molecules25040833. Molecules. 2020. PMID: 32075008 Free PMC article. Review.

2

Modulating the Blood-Brain Barrier: A Comprehensive Review.

Whelan R, Hargaden GC, Knox AJS. Whelan R, et al. Among authors: knox ajs. Pharmaceutics. 2021 Nov 22;13(11):1980. doi: 10.3390/pharmaceutics13111980. Pharmaceutics. 2021. PMID: 34834395 Free PMC article. Review.

3

Oncology exploration: charting cancer medicinal chemistry space.

Lloyd DG, Golfis G, Knox AJ, Fayne D, Meegan MJ, Oprea TI. Lloyd DG, et al. Among authors: knox aj. Drug Discov Today. 2006 Feb;11(3-4):149-59. doi: 10.1016/S1359-6446(05)03688-3. Drug Discov Today. 2006. PMID: 16533713 Review.

4

Estrogen receptors: molecular interactions, virtual screening and future prospects.

Knox AJ, Meegan MJ, Lloyd DG. Knox AJ, et al. Curr Top Med Chem. 2006;6(3):217-43. doi: 10.2174/156802606776173438. Curr Top Med Chem. 2006. PMID: 16515479 Review.

5

Synthesis and optimisation of P₃ substituted vinyl sulfone-based inhibitors as anti-trypanosomal agents.

Doherty W, Adler N, Butler TJ, Knox AJS, Evans P. Doherty W, et al. Among authors: knox ajs. Bioorg Med Chem. 2020 Dec 1;28(23):115774. doi: 10.1016/j.bmc.2020.115774. Epub 2020 Sep 20. Bioorg Med Chem. 2020. PMID: 32992251 Free article.

6

Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening.

Carr M, Knox AJS, Nevin DK, O'Boyle N, Wang S, Egan B, McCabe T, Twamley B, Zisterer DM, Lloyd DG, Meegan MJ. Carr M, et al. Among authors: knox ajs. Bioorg Med Chem. 2020 Mar 1;28(5):115261. doi: 10.1016/j.bmc.2019.115261. Epub 2019 Dec 24. Bioorg Med Chem. 2020. PMID: 31987694

7

β-Lactam estrogen receptor antagonists and a dual-targeting estrogen receptor/tubulin ligand.

O'Boyle NM, Pollock JK, Carr M, Knox AJ, Nathwani SM, Wang S, Caboni L, Zisterer DM, Meegan MJ. O'Boyle NM, et al. Among authors: knox aj. J Med Chem. 2014 Nov 26;57(22):9370-82. doi: 10.1021/jm500670d. Epub 2014 Nov 17. J Med Chem. 2014. PMID: 25369367

8

Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity.

O'Boyle NM, Barrett I, Greene LM, Carr M, Fayne D, Twamley B, Knox AJS, Keely NO, Zisterer DM, Meegan MJ. O'Boyle NM, et al. Among authors: knox ajs. J Med Chem. 2018 Jan 25;61(2):514-534. doi: 10.1021/acs.jmedchem.6b01917. Epub 2017 May 1. J Med Chem. 2018. PMID: 28426931

9

Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2.

Dinour D, Gray NK, Ganon L, Knox AJ, Shalev H, Sela BA, Campbell S, Sawyer L, Shu X, Valsamidou E, Landau D, Wright AF, Holtzman EJ. Dinour D, et al. Among authors: knox aj. Nephrol Dial Transplant. 2012 Mar;27(3):1035-41. doi: 10.1093/ndt/gfr419. Epub 2011 Aug 2. Nephrol Dial Transplant. 2012. PMID: 21810765

10

Target specific virtual screening: optimization of an estrogen receptor screening platform.

Knox AJ, Meegan MJ, Sobolev V, Frost D, Zisterer DM, Williams DC, Lloyd DG. Knox AJ, et al. J Med Chem. 2007 Nov 1;50(22):5301-10. doi: 10.1021/jm0700262. Epub 2007 Oct 5. J Med Chem. 2007. PMID: 17918820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year